Episurf Medical enters into distribution agreement for France
Episurf Medical (Nasdaq: EPIS B) today announces that the company has appointed In2Bones as distributor in France for Episurf Medical’s implant technology for the ankle. In2Bones is a global orthopaedic company, focusing on the extremity segment. The company is headquartered in the US but has a strong focus towards the French market. Earlier this year, Episurf Medical announced that the company’s knee and ankle implants, Episealer® Knee and Episealer® Talus, were registered and approved for sale in France, as the regulatory process with the French regulatory agency ANSM was completed.